Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
AXGN:NASDAQ
AxoGen, Inc Common Stock
42,63 $
-1,50%
(-0,65) 1D
42,63 $
0,00% (0,00)
After hours
Closed: 4 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXGN...
Open
43,17 $
High
43,28 $
Low
42,11 $
Mkt. cap
2,27 մլրդ
Avg. vol.
1,17 մլն
Volume
922,66 հզր
52-wk high
45,75 $
52-wk low
9,22 $
EPS
-0,64 $
Beta
1,17
Shares outstanding
53,18 մլն
No. of employees
622
News stories
From sources across the web
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websiteaxogeninc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
56,66 մլն
60,08 մլն
59,90 մլն
61,46 մլն
Cost of goods sold
14,64 մլն
14,09 մլն
15,50 մլն
15,27 մլն
Cost of revenue
14,64 մլն
14,09 մլն
15,50 մլն
15,27 մլն
Research and development expenses
6,85 մլն
7,56 մլն
12,38 մլն
7,52 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,49 մլն
36,52 մլն
41,80 մլն
41,50 մլն
Operating expense
40,35 մլն
44,08 մլն
54,18 մլն
49,02 մլն
Total operating expenses
54,99 մլն
58,17 մլն
69,68 մլն
64,29 մլն
Operating income
1,67 մլն
1,91 մլն
-9,77 մլն
-2,83 մլն
Other non operating income
659,00 հզր
234,00 հզր
-2,02 մլն
23,00 հզր
EBT including unusual items
579,00 հզր
708,00 հզր
-13,16 մլն
-19,58 մլն
EBT excluding unusual items
579,00 հզր
708,00 հզր
-13,16 մլն
-2,74 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
579,00 հզր
708,00 հզր
-13,16 մլն
-19,58 մլն
Net profit margin
1,02%
1,18%
-21,96%
-31,87%
Earnings per share
0,12
0,12
0,07
0,07
Interest and investment income
225,00 հզր
319,00 հզր
352,00 հզր
768,00 հզր
Interest expense
-1,98 մլն
-1,76 մլն
-1,72 մլն
-694,00 հզր
Net interest expenses
-1,75 մլն
-1,44 մլն
-1,37 մլն
74,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
3,40 մլն
3,64 մլն
-8,04 մլն
-1,13 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer